Eli Lilly Corp. buy UBS Group AG
Start price
08.08.25
/
50%
€537.70
Target price
08.08.26
€767.46
Performance (%)
66.82%
Price
16.12.25
€897.00
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Eli Lilly Corp. has seen massive gains of 66.82%. This prediction currently runs until 08.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 6.217% | 6.217% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at UBS Group AG from $1,050.00 to $895.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€781.50
07.11.25
07.11.25
€936.04
07.11.26
07.11.26
14.78%
16.12.25
16.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24